| _version_ |
1860797976138481664
|
| building |
INTELEK Repository
|
| collection |
Online Access
|
| collectionurl |
https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072
|
| date |
2024-08-30 11:14:16
|
| format |
Restricted Document
|
| id |
15224
|
| institution |
UniSZA
|
| internalnotes |
1. Ahmed I, Thiessard F, Miremont-Salamé G, Haramburu F, Kreft-Jais C, Bégaud B, Tubert-Bitter P. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study. Drug Saf, 2012; 35 (6): 495-506. 2. Moore N. The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist. Eur J Clin Pharmacol, 2013; 69 (Suppl 1): S33-S41. 3. Arencibia ZB, Leyva AL, Peña YM, Reyes ARG, Manzano EF, Choonara I. Pharmacovigilance in children in Camagüey Province, Cuba. Eur J Clin Pharmacol, 2012; 68 (7):1079-1084. 4. Salam A, Haque M, Islam MZ, Rahman NIA, Helali AM, Muda TFMBT, Yousuf R, Yesmin F, Rahman Z, Alattraqchi AG. Addressing Rational Prescribers through the Pharmacology and Therapeutics Course Work of MBBS Syllabus in Bangladesh. Int Res J Pharm, 2013; 4 (7): 60-63. 5. Islam MZ, Rahman MF, Mossaddek ASM, Rozario RJ, Iftekhar AFMH, Akhter S, Jahan I, Helali AM, Dali WPEW, Ismail S, Rahman NIA, Haque M. Bangladeshi Interns’ Knowledge of Pharmacology and Therapeutics for Prescribing. J App Pharm Sci, 2014; 4 (04): 043-051. 6. Moulis G, Sommet A, Durrieu G, Bagheri H, Lapeyre-Mestre M, Jean-Louis Montastruc J, French Association of PharmacoVigilance Centres. Trends of reporting of ‘serious’ vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database. Br J Clin Pharmacol, 2012; 74(1): 201-204. 7. Basch E. Systematic Collection of Patient-Reported Adverse Drug Reactions: A Path to Patient-Centred Pharmacovigilance. Drug Saf, 2013; 36 (4):277-278. 8. Stewart D, MacLure K, Paudyal V, Hughes C, Courtenay M, McLay J . Non-medical prescribers and pharmacovigilance: participation, competence and future needs. Int J Clin Pharm, 2013; 35 (2):268- 274. 9. Kabore L, Millet P, Fofana S, Berdai D, Adam C, Haramburu F. Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso. Drug Saf, 2013; 36 (5):349-358. 10. Mehta U, Dheda M, Steel G, Blockman M, Ntilivamunda A, Maartens G, Pillay Y, Cohen K. Strengthening pharmacovigilance in South Africa. SAMJ, 2014; 104 (2): 104-106. 11. Smith MP, Webley SD. Pharmacovigilance teaching in UK undergraduate pharmacy Programmes. Pharmepidemiol Drug Saf, 2013; 22: 223-228. 12. Dinnett EM, Kean S, Tolmie EP, Ronald ES, Gaw A. Implementing a centralized pharmacovigilance service in a non-commercial setting in the United Kingdom. Trials, 2013; 14:171. 13. Rodrigues E, Barnes J. Pharmacovigilance of Herbal Medicines: The Potential Contributions of Ethnobotanical and Ethnopharmacological Studies. Drug Saf, 2013; 36 (1):1-12. 14. World Health Organisation. International Drug Monitoring: The role of National Centers. Report of a WHO meeting. Geneva, Switzerland. WHO Tech Rep Ser, 1972; 498: 1-25. 15. Abubakar AR, Simbak NB, Haque M. Adverse Drug Reactions: Predisposing Factors, Modern Classifications and Causality Assessment. Research J Pharm Tech, 2014a; 7(9): 1091-1098. 16. Abubakar AR, Simbak NB, Haque M. A Systematic Review of Knowledge, Attitude and Practice on Adverse Drug Reactions and Pharmacovigilance among Doctors. J App Pharm Sci, 2014b; 4(11): 117- 27. 17. Edward IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet, 2000; 356 (9237): 1255-1259. 18. World Health Organisation. The importance of pharmacovigilance Safety Monitoring of medicinal products. Geneva, Switzerland, 2002. 19. Abubakar AR, Chedi BAZ; Simbak NB, Haque M. Medication error: The role of health care professionals, sources of error and prevention strategies. Journal of Chemical and Pharmaceutical Research, 2014c; 6 (10): 646-651. 20. Kamtane RA, Jayawardhani V. Knowledge, Attitude and Perception of Physicians towards Adverse Drug Reaction (ADR) Reporting: A Pharmacoepidemiological Study. Asian J Pharm Clin Res, 2012; 5 (Suppl 3): 210-214. 21. Reddy VL, Pasha SKJ, Rathinavelu M, Reddy YP. Assessment of Knowledge, Attitude and Perception of Pharmacovigilance and Adverse Drug Reaction (ADR) Reporting among the Pharmacy Students in South India. IOSR-JPBS, 2014; 9 (2): 34-43. 22. Vora MB, Paliwal NP, Doshi VG, Barvaliya MJ, Tripathi CB. Knowledge of Adverse Drug Reactions and Pharmacovigilance Activity among the Undergraduate Medical Students of Gujarat. IJPSR, 2012; 3(5): 1511-1515. 23. Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: Knowledge, attitude and practices of medical students and prescribers. Nat Med J India, 2002; 15(1):24 -26. 24. Hema NG, Bhuvana KB, Sangeetha. Pharmacovigilance: The Extent of Awareness among the Final Year Students, Interns and Postgraduates in a Government Teaching Hospital. J Clin Diagn Res, 2012; 6(7): 1248-1253. 25. Sivadasan S, Yuong NY, Chyi NW, Ching ALS, Ali AN, Veerasamy R, Marimuthub K, Arumugama DS. Knowledge and Perception towards Pharmacovigilance and Adverse Drug Reaction Reporting among Medicine and Pharmacy Students. WJPPS, 2014; 3(3): 1652-1676. 26. Ismail SB, Rahman NIA, Anantrao NH, Dali WPEW, Umar BD, Haque M. Awareness of Pharmacovigilance among Future House Officers; a Study among First Batch of Final Year Medical Students of UniSZA, Malaysia. Int Med J, 2015 (In Press) 27. Isfahani ME, Mousavi S, Rakhshan A, Assarian M, Kuti L, Eslami K. Adverse Drug Reactions: Knowledge, Attitude and Practice of Pharmacy Students. J Pharm Care, 2013; 1(4): 145-148. 28. Durrieu G, Hurault C, Bongard V, Damase-Michel C, Ontastruc JL. Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course. Br J Clin Pharmacol, 2007; 64(2): 233-236.
|
| originalfilename |
5993-01-FH02-FP-15-03249.pdf
|
| person |
Cisco
|
| recordtype |
oai_dc
|
| resourceurl |
https://intelek.unisza.edu.my/intelek/pages/view.php?ref=15224
|
| spelling |
15224 https://intelek.unisza.edu.my/intelek/pages/view.php?ref=15224 https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 Restricted Document Article Journal application/pdf Adobe Acrobat Pro DC 20 Paper Capture Plug-in with ClearScan 8 1.6 Cisco 2024-08-30 11:14:16 5993-01-FH02-FP-15-03249.pdf UniSZA Private Access Pharmacovigilance Study: Awareness among Medical Students of a New Medical School of Malaysia International Journal of Pharmaceutical Research Patients take medicine for the treatment of their illness and medicine is a double edge sword, thus causes harm beside their therapeutic benefit. Pharmacovigilance program was designed to monitor and report the harmful effects of drugs after they are marketed for use by the larger society. This research was aimed at assessing the medical students’ knowledge, attitude and practice with respect to adverse drug reaction and its surveillance. The questionnaire was adopted, modified and validated from previous studies. It comprised of 25 questions (Knowledge-10, Attitude-7 and Practice-8). It was administered Year-IV and V medical students of Universiti Sultan Zainal Abidin. The data collected was coded and analyzed using the SPSS version 20. The response rate was 74%. Sixty-eight percent knows the definition of adverse drug reactions correctly; 59% of them recognized the right functions of pharmacovigilance. In contrast, only 21% know the method commonly used in adverse drug reactions reporting and only 15% are aware of any nearby pharmacovigilance center. Eighty-seven percent strongly agree that adverse drug reactions reporting is professional obligation; 98% think adverse drug reactions reporting will benefit patients. Ninety-four percent have never received any training on how to report adverse drug reactions. In addition, 72% have come across adverse drug reactions but avoided to contact appropriate authority. The overall medical students’ knowledge on adverse drug reactions and its surveillance was not enough; even though they had good attitudes their practice remained very poor. This has call for adjustment of medical students’ curriculum with respect to pharmacovigilance study. 7 1 83-88 1. Ahmed I, Thiessard F, Miremont-Salamé G, Haramburu F, Kreft-Jais C, Bégaud B, Tubert-Bitter P. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study. Drug Saf, 2012; 35 (6): 495-506. 2. Moore N. The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist. Eur J Clin Pharmacol, 2013; 69 (Suppl 1): S33-S41. 3. Arencibia ZB, Leyva AL, Peña YM, Reyes ARG, Manzano EF, Choonara I. Pharmacovigilance in children in Camagüey Province, Cuba. Eur J Clin Pharmacol, 2012; 68 (7):1079-1084. 4. Salam A, Haque M, Islam MZ, Rahman NIA, Helali AM, Muda TFMBT, Yousuf R, Yesmin F, Rahman Z, Alattraqchi AG. Addressing Rational Prescribers through the Pharmacology and Therapeutics Course Work of MBBS Syllabus in Bangladesh. Int Res J Pharm, 2013; 4 (7): 60-63. 5. Islam MZ, Rahman MF, Mossaddek ASM, Rozario RJ, Iftekhar AFMH, Akhter S, Jahan I, Helali AM, Dali WPEW, Ismail S, Rahman NIA, Haque M. Bangladeshi Interns’ Knowledge of Pharmacology and Therapeutics for Prescribing. J App Pharm Sci, 2014; 4 (04): 043-051. 6. Moulis G, Sommet A, Durrieu G, Bagheri H, Lapeyre-Mestre M, Jean-Louis Montastruc J, French Association of PharmacoVigilance Centres. Trends of reporting of ‘serious’ vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database. Br J Clin Pharmacol, 2012; 74(1): 201-204. 7. Basch E. Systematic Collection of Patient-Reported Adverse Drug Reactions: A Path to Patient-Centred Pharmacovigilance. Drug Saf, 2013; 36 (4):277-278. 8. Stewart D, MacLure K, Paudyal V, Hughes C, Courtenay M, McLay J . Non-medical prescribers and pharmacovigilance: participation, competence and future needs. Int J Clin Pharm, 2013; 35 (2):268- 274. 9. Kabore L, Millet P, Fofana S, Berdai D, Adam C, Haramburu F. Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso. Drug Saf, 2013; 36 (5):349-358. 10. Mehta U, Dheda M, Steel G, Blockman M, Ntilivamunda A, Maartens G, Pillay Y, Cohen K. Strengthening pharmacovigilance in South Africa. SAMJ, 2014; 104 (2): 104-106. 11. Smith MP, Webley SD. Pharmacovigilance teaching in UK undergraduate pharmacy Programmes. Pharmepidemiol Drug Saf, 2013; 22: 223-228. 12. Dinnett EM, Kean S, Tolmie EP, Ronald ES, Gaw A. Implementing a centralized pharmacovigilance service in a non-commercial setting in the United Kingdom. Trials, 2013; 14:171. 13. Rodrigues E, Barnes J. Pharmacovigilance of Herbal Medicines: The Potential Contributions of Ethnobotanical and Ethnopharmacological Studies. Drug Saf, 2013; 36 (1):1-12. 14. World Health Organisation. International Drug Monitoring: The role of National Centers. Report of a WHO meeting. Geneva, Switzerland. WHO Tech Rep Ser, 1972; 498: 1-25. 15. Abubakar AR, Simbak NB, Haque M. Adverse Drug Reactions: Predisposing Factors, Modern Classifications and Causality Assessment. Research J Pharm Tech, 2014a; 7(9): 1091-1098. 16. Abubakar AR, Simbak NB, Haque M. A Systematic Review of Knowledge, Attitude and Practice on Adverse Drug Reactions and Pharmacovigilance among Doctors. J App Pharm Sci, 2014b; 4(11): 117- 27. 17. Edward IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet, 2000; 356 (9237): 1255-1259. 18. World Health Organisation. The importance of pharmacovigilance Safety Monitoring of medicinal products. Geneva, Switzerland, 2002. 19. Abubakar AR, Chedi BAZ; Simbak NB, Haque M. Medication error: The role of health care professionals, sources of error and prevention strategies. Journal of Chemical and Pharmaceutical Research, 2014c; 6 (10): 646-651. 20. Kamtane RA, Jayawardhani V. Knowledge, Attitude and Perception of Physicians towards Adverse Drug Reaction (ADR) Reporting: A Pharmacoepidemiological Study. Asian J Pharm Clin Res, 2012; 5 (Suppl 3): 210-214. 21. Reddy VL, Pasha SKJ, Rathinavelu M, Reddy YP. Assessment of Knowledge, Attitude and Perception of Pharmacovigilance and Adverse Drug Reaction (ADR) Reporting among the Pharmacy Students in South India. IOSR-JPBS, 2014; 9 (2): 34-43. 22. Vora MB, Paliwal NP, Doshi VG, Barvaliya MJ, Tripathi CB. Knowledge of Adverse Drug Reactions and Pharmacovigilance Activity among the Undergraduate Medical Students of Gujarat. IJPSR, 2012; 3(5): 1511-1515. 23. Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: Knowledge, attitude and practices of medical students and prescribers. Nat Med J India, 2002; 15(1):24 -26. 24. Hema NG, Bhuvana KB, Sangeetha. Pharmacovigilance: The Extent of Awareness among the Final Year Students, Interns and Postgraduates in a Government Teaching Hospital. J Clin Diagn Res, 2012; 6(7): 1248-1253. 25. Sivadasan S, Yuong NY, Chyi NW, Ching ALS, Ali AN, Veerasamy R, Marimuthub K, Arumugama DS. Knowledge and Perception towards Pharmacovigilance and Adverse Drug Reaction Reporting among Medicine and Pharmacy Students. WJPPS, 2014; 3(3): 1652-1676. 26. Ismail SB, Rahman NIA, Anantrao NH, Dali WPEW, Umar BD, Haque M. Awareness of Pharmacovigilance among Future House Officers; a Study among First Batch of Final Year Medical Students of UniSZA, Malaysia. Int Med J, 2015 (In Press) 27. Isfahani ME, Mousavi S, Rakhshan A, Assarian M, Kuti L, Eslami K. Adverse Drug Reactions: Knowledge, Attitude and Practice of Pharmacy Students. J Pharm Care, 2013; 1(4): 145-148. 28. Durrieu G, Hurault C, Bongard V, Damase-Michel C, Ontastruc JL. Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course. Br J Clin Pharmacol, 2007; 64(2): 233-236.
|
| spellingShingle |
Pharmacovigilance Study: Awareness among Medical Students of a New Medical School of Malaysia
|
| summary |
Patients take medicine for the treatment of their illness and medicine is a double edge sword, thus causes harm beside their therapeutic benefit. Pharmacovigilance program was designed to monitor and report the harmful effects of drugs after they are marketed for use by the larger society. This research was aimed at assessing the medical students’ knowledge, attitude and practice with respect to adverse drug reaction and its surveillance. The questionnaire was adopted, modified and validated from previous studies. It comprised of 25 questions (Knowledge-10, Attitude-7 and Practice-8). It was administered Year-IV and V medical students of Universiti Sultan Zainal Abidin. The data collected was coded and analyzed using the SPSS version 20. The response rate was 74%. Sixty-eight percent knows the definition of adverse drug reactions correctly; 59% of them recognized the right functions of pharmacovigilance. In contrast, only 21% know the method commonly used in adverse drug reactions reporting and only 15% are aware of any nearby pharmacovigilance center. Eighty-seven percent strongly agree that adverse drug reactions reporting is professional obligation; 98% think adverse drug reactions reporting will benefit patients. Ninety-four percent have never received any training on how to report adverse drug reactions. In addition, 72% have come across adverse drug reactions but avoided to contact appropriate authority. The overall medical students’ knowledge on adverse drug reactions and its surveillance was not enough; even though they had good attitudes their practice remained very poor. This has call for adjustment of medical students’ curriculum with respect to pharmacovigilance study.
|
| title |
Pharmacovigilance Study: Awareness among Medical Students of a New Medical School of Malaysia
|
| title_full |
Pharmacovigilance Study: Awareness among Medical Students of a New Medical School of Malaysia
|
| title_fullStr |
Pharmacovigilance Study: Awareness among Medical Students of a New Medical School of Malaysia
|
| title_full_unstemmed |
Pharmacovigilance Study: Awareness among Medical Students of a New Medical School of Malaysia
|
| title_short |
Pharmacovigilance Study: Awareness among Medical Students of a New Medical School of Malaysia
|
| title_sort |
pharmacovigilance study: awareness among medical students of a new medical school of malaysia
|